dextroamphetamine has been researched along with Hypomania in 3 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Therefore, LIRA can reverse some mania-like behavioral alterations and combined with Li augmented the mood stabilizing and neuroprotective properties of Li." | 5.56 | The GLP-1 receptor agonist liraglutide reverses mania-like alterations and memory deficits induced by D-amphetamine and augments lithium effects in mice: Relevance for bipolar disorder. ( Barichello, T; Chaves Filho, AJM; Cunha, NL; de Lucena, D; de Queiroz, T; de Souza, AG; Jucá, PM; Macedo, DS; Oliveira, JVS; Quevedo, J; Soares, MV; Valvassori, SS, 2020) |
| "Therefore, LIRA can reverse some mania-like behavioral alterations and combined with Li augmented the mood stabilizing and neuroprotective properties of Li." | 1.56 | The GLP-1 receptor agonist liraglutide reverses mania-like alterations and memory deficits induced by D-amphetamine and augments lithium effects in mice: Relevance for bipolar disorder. ( Barichello, T; Chaves Filho, AJM; Cunha, NL; de Lucena, D; de Queiroz, T; de Souza, AG; Jucá, PM; Macedo, DS; Oliveira, JVS; Quevedo, J; Soares, MV; Valvassori, SS, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaves Filho, AJM | 2 |
| Cunha, NL | 2 |
| de Souza, AG | 2 |
| Soares, MV | 2 |
| Jucá, PM | 2 |
| de Queiroz, T | 2 |
| Oliveira, JVS | 1 |
| Valvassori, SS | 1 |
| Barichello, T | 1 |
| Quevedo, J | 1 |
| de Lucena, D | 1 |
| Macedo, DS | 2 |
| Rodrigues, PA | 1 |
| Clemente, DCDS | 1 |
| Mottin, M | 1 |
| Andrade, CH | 1 |
| Peixoto, CA | 1 |
| Wöhr, M | 1 |
1 review available for dextroamphetamine and Hypomania
| Article | Year |
|---|---|
Measuring mania-like elevated mood through amphetamine-induced 50-kHz ultrasonic vocalizations in rats.
Topics: Amphetamine; Animals; Antimanic Agents; Dextroamphetamine; Mania; Rats; Ultrasonics; Vocalization, A | 2022 |
2 other studies available for dextroamphetamine and Hypomania
| Article | Year |
|---|---|
The GLP-1 receptor agonist liraglutide reverses mania-like alterations and memory deficits induced by D-amphetamine and augments lithium effects in mice: Relevance for bipolar disorder.
Topics: Animals; Bipolar Disorder; Dextroamphetamine; Drug Synergism; Glucagon-Like Peptide-1 Receptor; Lipi | 2020 |
Doxycycline reverses cognitive impairment, neuroinflammation and oxidative imbalance induced by D-amphetamine mania model in mice: A promising drug repurposing for bipolar disorder treatment?
Topics: Animals; Antimanic Agents; Bipolar Disorder; Cognitive Dysfunction; Dextroamphetamine; Disease Model | 2021 |